drugset / Trial / NCT04518202

Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

NCT04518202 ↗

Unknown 200 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Timeline

Start
2020-09-01
Primary completion
2021-08-31
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % —

Indications